Feasibility of a Social-emotional Learning Curriculum in an After-school Program for Youth
Launched by CENTRE FOR ADDICTION AND MENTAL HEALTH · Sep 27, 2024
Trial Information
Current as of May 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new social-emotional learning curriculum designed to help young people improve their social skills, resilience, and overall functioning. The study focuses on the Beyond 3:30 after-school program, where youth aged 11-14 will participate. The main goals are to see if the new curriculum is practical and accepted by both program staff and participants, and to measure if it helps students develop better social-emotional skills and cope with challenges more effectively.
To be eligible for the study, youth must be between 11 and 14 years old and enrolled in the Beyond 3:30 program. They, along with their parents and the program facilitators, will need to understand and sign consent forms in English. Participants can expect to engage in activities that promote social-emotional learning and provide feedback on their experiences. The trial is not yet recruiting participants, but it aims to gather important information on how effective this new curriculum can be in supporting youth development.
Gender
ALL
Eligibility criteria
- INCLUSION:
- Youth participants must meet the following inclusion criteria:
- • 1. Must be a youth aged 11-14 years attending the beyond 3:30 program
- • 2. Must sign and date the informed consent form
- • 3. Must speak and understand English
- Staff participants must meet the following inclusion criteria:
- • 1. Must be a facilitator of the beyond 3:30 program
- • 2. Must sign and date the informed consent form
- • 3. Must speak and understand English
- Caregiver/parent participants must meet the following inclusion criteria:
- • 1. Must be a caregiver/parent of a youth aged 11-14 years attending the beyond 3:30 program. Caregivers/parents whose children decide not to participate in data collection are still able to participate in an interview post-SEL curriculum implementation.
- • 2. Must sign and date the informed consent form
- • 3. Must speak and understand English
- • EXCLUSION; None
About Centre For Addiction And Mental Health
The Centre for Addiction and Mental Health (CAMH) is Canada’s leading mental health and addiction teaching hospital, dedicated to advancing research, clinical care, and education in the field of mental health. With a commitment to improving the lives of individuals affected by mental illness and addiction, CAMH conducts innovative clinical trials aimed at developing and evaluating new treatment approaches. The institution fosters a collaborative environment that brings together researchers, clinicians, and community partners to translate scientific findings into effective interventions, ensuring the highest standards of care and support for patients. Through its robust research initiatives, CAMH strives to enhance understanding of mental health disorders and promote evidence-based practices in the treatment of addiction and mental health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Brendan F Andrade, PhD
Principal Investigator
Centre for Addiction and Mental Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported